126 related articles for article (PubMed ID: 8443592)
21. FAIMS and Phosphoproteomics of Fibroblast Growth Factor Signaling: Enhanced Identification of Multiply Phosphorylated Peptides.
Zhao H; Cunningham DL; Creese AJ; Heath JK; Cooper HJ
J Proteome Res; 2015 Dec; 14(12):5077-87. PubMed ID: 26503514
[TBL] [Abstract][Full Text] [Related]
22. Differential activation of cysteine-substitution mutants of fibroblast growth factor receptor 3 is determined by cysteine localization.
Adar R; Monsonego-Ornan E; David P; Yayon A
J Bone Miner Res; 2002 May; 17(5):860-8. PubMed ID: 12009017
[TBL] [Abstract][Full Text] [Related]
23. Two hierarchies of FGF-2 signaling in heparin: mitogenic stimulation and high-affinity binding/receptor transphosphorylation.
Krufka A; Guimond S; Rapraeger AC
Biochemistry; 1996 Aug; 35(34):11131-41. PubMed ID: 8780517
[TBL] [Abstract][Full Text] [Related]
24. Differential effects of heparin, fibronectin, and laminin on the phosphorylation of basic fibroblast growth factor by protein kinase C and the catalytic subunit of protein kinase A.
Feige JJ; Bradley JD; Fryburg K; Farris J; Cousens LC; Barr PJ; Baird A
J Cell Biol; 1989 Dec; 109(6 Pt 1):3105-14. PubMed ID: 2592418
[TBL] [Abstract][Full Text] [Related]
25. Autophosphorylation of KDR in the kinase domain is required for maximal VEGF-stimulated kinase activity and receptor internalization.
Dougher M; Terman BI
Oncogene; 1999 Feb; 18(8):1619-27. PubMed ID: 10102632
[TBL] [Abstract][Full Text] [Related]
26. Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia.
Naski MC; Wang Q; Xu J; Ornitz DM
Nat Genet; 1996 Jun; 13(2):233-7. PubMed ID: 8640234
[TBL] [Abstract][Full Text] [Related]
27. Internalization of fibroblast growth factor receptor is inhibited by a point mutation at tyrosine 766.
Sorokin A; Mohammadi M; Huang J; Schlessinger J
J Biol Chem; 1994 Jun; 269(25):17056-61. PubMed ID: 7516330
[TBL] [Abstract][Full Text] [Related]
28. Amino acid residues which distinguish the mitogenic potentials of two FGF receptors.
Wang JK; Goldfarb M
Oncogene; 1997 Apr; 14(15):1767-78. PubMed ID: 9150382
[TBL] [Abstract][Full Text] [Related]
29. Regulation of the human c-fes protein tyrosine kinase (p93c-fes) by its src homology 2 domain and major autophosphorylation site (Tyr-713).
Hjermstad SJ; Peters KL; Briggs SD; Glazer RI; Smithgall TE
Oncogene; 1993 Aug; 8(8):2283-92. PubMed ID: 7687763
[TBL] [Abstract][Full Text] [Related]
30. Multiple in vivo tyrosine phosphorylation sites in EphB receptors.
Kalo MS; Pasquale EB
Biochemistry; 1999 Oct; 38(43):14396-408. PubMed ID: 10572014
[TBL] [Abstract][Full Text] [Related]
31. Selective inhibition of fibroblast growth factor (FGF)-stimulated mitogenesis by a FGF receptor-1-derived phosphopeptide.
Dunican DJ; Williams EJ; Howell FV; Doherty P
Cell Growth Differ; 2001 May; 12(5):255-64. PubMed ID: 11373272
[TBL] [Abstract][Full Text] [Related]
32. Focal adhesion kinase tyrosine-861 is a major site of phosphorylation by Src.
Calalb MB; Zhang X; Polte TR; Hanks SK
Biochem Biophys Res Commun; 1996 Nov; 228(3):662-8. PubMed ID: 8941336
[TBL] [Abstract][Full Text] [Related]
33. Expression and glycosylation studies of human FGF receptor 4.
Tuominen H; Heikinheimo P; Loo BM; Kataja K; Oker-Blom C; Uutela M; Jalkanen M; Goldman A
Protein Expr Purif; 2001 Mar; 21(2):275-85. PubMed ID: 11237689
[TBL] [Abstract][Full Text] [Related]
34. Fibroblast growth factor receptor 3 lacking the Ig IIIb and transmembrane domains secreted from human squamous cell carcinoma DJM-1 binds to FGFs.
Terada M; Shimizu A; Sato N; Miyakaze SI; Katayama H; Kurokawa-Seo M
Mol Cell Biol Res Commun; 2001 Nov; 4(6):365-73. PubMed ID: 11703096
[TBL] [Abstract][Full Text] [Related]
35. Characterization of FGFRL1, a novel fibroblast growth factor (FGF) receptor preferentially expressed in skeletal tissues.
Trueb B; Zhuang L; Taeschler S; Wiedemann M
J Biol Chem; 2003 Sep; 278(36):33857-65. PubMed ID: 12813049
[TBL] [Abstract][Full Text] [Related]
36. Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors.
Mohammadi M; McMahon G; Sun L; Tang C; Hirth P; Yeh BK; Hubbard SR; Schlessinger J
Science; 1997 May; 276(5314):955-60. PubMed ID: 9139660
[TBL] [Abstract][Full Text] [Related]
37. Analysis of putative heparin-binding domains of fibroblast growth factor-1. Using site-directed mutagenesis and peptide analogues.
Wong P; Hampton B; Szylobryt E; Gallagher AM; Jaye M; Burgess WH
J Biol Chem; 1995 Oct; 270(43):25805-11. PubMed ID: 7592764
[TBL] [Abstract][Full Text] [Related]
38. Production and characterization of the extracellular domain of recombinant human fibroblast growth factor receptor 4.
Loo BB; Darwish KK; Vainikka SS; Saarikettu JJ; Vihko PP; Hermonen JJ; Goldman AA; Alitalo KK; Jalkanen MM
Int J Biochem Cell Biol; 2000 May; 32(5):489-97. PubMed ID: 10736564
[TBL] [Abstract][Full Text] [Related]
39. Ligand binding properties of binary complexes of heparin and immunoglobulin-like modules of FGF receptor 2.
Uematsu F; Kan M; Wang F; Jang JH; Luo Y; McKeehan WL
Biochem Biophys Res Commun; 2000 Jun; 272(3):830-6. PubMed ID: 10860838
[TBL] [Abstract][Full Text] [Related]
40. The epidermal growth factor receptor (EGFR) and proline rich tyrosine kinase 2 (PYK2) are involved in tissue factor dependent factor VIIa signalling in HaCaT cells.
Wiiger MT; Prydz H
Thromb Haemost; 2004 Jul; 92(1):13-22. PubMed ID: 15213840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
